ALFSYNPRA
Live / Applied — Second extension granted (statement of use) (as of 20 Oct 2025)
What this means for you
Not registered yet, but its 17 Apr 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98504659
- Mark type
- Stylized text
- Filed
- 17 Apr 2024
- Published for opposition
- 01 Oct 2024
- Attorney of record
- Jelena Libby
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of neurological and neurodegenerative diseases
Owner
- Genentech, Inc., South San Francisco, CA, US
- Genentech, Inc., South San Francisco, CA, US
Prosecution history
- 21 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Oct 2025 — SOU EXTENSION 2 GRANTED
- 20 Oct 2025 — SOU EXTENSION 2 FILED
- 20 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 23 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 May 2025 — SOU EXTENSION 1 GRANTED
- 22 May 2025 — SOU EXTENSION 1 FILED
- 22 May 2025 — SOU TEAS EXTENSION RECEIVED
- 26 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Oct 2024 — PUBLISHED FOR OPPOSITION
- 11 Sept 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Aug 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 31 Jul 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 Jul 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE